State Controller Calls for Audit Of Stem Cell Institute's Expenditures
By Joyce E. Cutler,
Bureau of National Affairs
| 11. 29. 2007
[Quotes CGS's Jesse Reynolds]
California Controller John Chiang (D) Nov. 28 called for an audit of all proceeds of the California Institute for Regenerative Medicine (CIRM), the voter-created office overseeing $3 billion in bonds sold to fund stem cell research.
Chiang announced the audit while chairing the annual meeting of the Citizens Financial Accountability Oversight Committee with results due in time for the committee's meeting next spring.
The controller, noting that $250 million in bonds already were sold, directed his staff to audit grant management, financial risk, expenditures, and procedures for avoiding conflicts of interest.
Chiang also asked the state Fair Political Practices Commission (FPPC) for a full review of whether Independent Citizens' Oversight Committee member John Reed violated conflict-of-interest rules. Reed wrote a letter asking why CIRM denied a grant to a scientist who works for him at the Burnham Institute for Medical Research in La Jolla, Calif.
The ICOC is CIRM's governing board. Members are required to refrain from participating in or influencing decisions involving their employers. No changes resulted from Reed's letter, interim CIRM President Richard Murphy said.
Chiang said it...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Charles Schmidt, Undark | 09.25.2026
In 2010, scientists at the University of Tokyo and other institutions reported a startling achievement: They had successfully grown a pancreas made almost entirely of rat cells within the bodies of mice. The research was directed by Hiromitsu Nakauchi, a...
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
